Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Can the O-Shot help with discomfort during intimacy?
The O-Shot may be worth discussing for selected patients whose discomfort during intimacy is linked with dryness, tissue quality, arousal response, or menopausal change, but pain during sex needs proper assessment.
Direct answer
The O-Shot may be worth discussing for selected patients whose discomfort during intimacy is linked with dryness, tissue quality, arousal response, or menopausal change, but pain during sex needs proper assessment.
The most useful plan starts with the underlying cause, not the treatment name. Your clinician should review symptoms, medical history, alternatives, expected benefits, limitations and safety.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.
At a glance
These are the main points to understand before deciding whether this option is suitable.
At a glance
Clinical summary
Treatment Type
Non-surgical, minimally invasive regenerative medicine using autologous (your own) blood.
Mechanism
Concentrates platelets via a centrifuge to release growth factors that repair damaged tissues, boost collagen, and increase blood.
Primary Indications
Dyspareunia (painful sex), vaginal dryness, vulvovaginal atrophy (often due to menopause), lichen sclerosus, and female sexual dysfunction (including.
Procedure Time
Approximately 30 to 60 minutes in an outpatient clinic.
Important safety note
reported safety profile: Because the O-Shot uses the patient's own blood, there is low but not absent risk of allergic reaction or immune rejection.
Suitability
Evidence
Safety
Aftercare
Detailed answer
Detailed answer
• Evidence Base: Clinical trials have shown reported improvements in the Female Sexual Function Index (FSFI), specifically in domains related to pain, lubrication, and overall satisfaction.
Clinical context
Evidence Base: Clinical trials have shown reported improvements in the Female Sexual Function Index (FSFI), specifically in domains related to pain, lubrication, and overall satisfaction.
Evidence
Symptoms
Alternatives
What it means
Evidence Base: Clinical trials have shown reported improvements in the Female Sexual Function Index (FSFI), specifically in domains related to pain, lubrication, and overall satisfaction.
Why it happens
Menopausal/Atrophy Relief: Studies note that PRP is highly effective in relieving symptoms of genitourinary syndrome of menopause (GSM), serving as a promising alternative for women who cannot.
Evidence limits
Variation in Results: While a vast majority of patients report enhanced pleasure and reduced pain, results are subjective and can vary based on age, medical history.
Treatment fit
Combination Therapies: PRP is sometimes combined with energy-based treatments (like radiofrequency or lasers) or hyaluronic acid to maximize tissue regeneration.
What this means in practice
• Costs should be confirmed on the /pricing/ page before booking
• Immediate Post-Procedure: Patients can return to normal daily activities on the same day, with minimal downtime. • Onset of Results: Initial improvements in vaginal lubrication and sensitivity are typically noticed within 3 to 4 weeks.
Patient safety
Why proper assessment matters
Assessment helps separate marketing claims from safe, individualised clinical decision-making.
It checks the cause
Evidence Base: Clinical trials have shown reported improvements in the Female Sexual Function Index (FSFI), specifically in domains related to pain, lubrication, and overall satisfaction.
It protects safety
reported safety profile: Because the O-Shot uses the patient's own blood, there is low but not absent risk of allergic reaction or immune rejection.
It reviews alternatives
Costs should be confirmed on the /pricing/ page before booking
It sets expectations
Immediate Post-Procedure: Patients can return to normal daily activities on the same day, with minimal downtime.
A clinical decision, not a shortcut
The safest final page should explain what the intervention may do, what it cannot promise, and when another route may be better.
Treatment should be discussed with realistic goals, informed consent, clear aftercare and a plan for review.
Considerations
What to consider
• Costs should be confirmed on the /pricing/ page before booking
Consultation priorities
Step 1: Consultation: A comprehensive assessment with a specialist to discuss symptoms, rule out contraindications, and determine if PRP is the right approach.
Consent
Aftercare
Follow-up
Before treatment
Step 1: Consultation: A comprehensive assessment with a specialist to discuss symptoms, rule out contraindications, and determine if PRP is the right approach.
During care
Step 2: Blood Draw: A small sample of blood (roughly 10-60ml) is drawn from the patient's arm.
Aftercare
Step 3: Centrifugation: The blood is spun in a specialised machine to separate and concentrate the platelet-rich plasma.
When to reassess
Step 4: Numbing: A potent topical numbing cream (and occasionally a local anaesthetic injection) is applied to the vulva, clitoris, and internal vaginal walls to ensure comfort.
Practical expectations
Immediate Post-Procedure: Patients can return to normal daily activities on the same day, with minimal downtime.
Preparation: Patients may be advised to avoid anti-inflammatory medications (like ibuprofen) for a few days before the procedure, as these can interfere with the inflammatory healing process initiated.
Common concerns and myths
Common misconceptions
Clear patient information should correct over-simple claims and keep expectations realistic.
Myth: Pain during sex is always caused by dryness.
Reality: suitability depends on the symptom pattern, medical history, contraindications, alternatives and individual goals.
Myth: One treatment pathway suits every type of discomfort.
Reality: results vary, evidence may be developing, and non-response should prompt reassessment.
Myth: Discomfort should be ignored if it is common after menopause.
Reality: injections, devices and intimate procedures can still carry risks and need proper consent and aftercare.
Evidence and advertising
Menopausal/Atrophy Relief: Studies note that PRP is highly effective in relieving symptoms of genitourinary syndrome of menopause (GSM), serving as a promising alternative for women who cannot.
Alternatives
Costs should be confirmed on the /pricing/ page before booking
Safety checklist
Safety checklist
Use these questions to decide whether treatment should be discussed, delayed or redirected.
Has the cause been assessed?
Symptoms should be reviewed in context before selecting a treatment.
Are red flags absent?
reported safety profile: Because the O-Shot uses the patient's own blood, there is low but not absent risk of allergic reaction or immune rejection.
Are alternatives clear?
Costs should be confirmed on the /pricing/ page before booking
Is follow-up planned?
The clinic should explain aftercare, review timing and when to seek help.
Reassuring signs
Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.
No red flags
Follow-up plan
Reasons to pause
reported safety profile: Because the O-Shot uses the patient's own blood, there is low but not absent risk of allergic reaction or immune rejection.
Bleeding
Infection
When to escalate
When to seek medical help
Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online
Severe or worsening pain
reported safety profile: Because the O-Shot uses the patient's own blood, there is low but not absent risk of allergic reaction or immune rejection.
Bleeding or discharge
Common Side Effects: Mild, temporary side effects may include spotting, slight numbness from the local anaesthetic, or minor swelling and tenderness at the injection sites, which usually resolve.
Infection signs
Red Flags/Contraindications: PRP is not recommended for individuals with active pelvic or urinary tract infections, undiagnosed vaginal bleeding, severe bleeding/platelet disorders, or hemodynamic instability.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Benchmark positioning
- The best page turns an intimate, vague search into a reassuring assessment pathway with PRP placed as one possible option.
Clinical reality
- Evidence Base: Clinical trials have shown reported improvements in the Female Sexual Function Index (FSFI), specifically in domains related to pain, lubrication, and overall satisfaction.
- Menopausal/Atrophy Relief: Studies note that PRP is highly effective in relieving symptoms of genitourinary syndrome of menopause (GSM), serving as a promising alternative for women who cannot or prefer not to use hormone replacement.
- Variation in Results: While a vast majority of patients report enhanced pleasure and reduced pain, results are subjective and can vary based on age, medical history, and the severity of the underlying condition.
- Combination Therapies: PRP is sometimes combined with energy-based treatments (like radiofrequency or lasers) or hyaluronic acid to maximize tissue regeneration.
Timeline and expectations
- Immediate Post-Procedure: Patients can return to normal daily activities on the same day, with minimal downtime.
- Onset of Results: Initial improvements in vaginal lubrication and sensitivity are typically noticed within 3 to 4 weeks.
- Peak Results: Full benefits and optimal tissue regeneration generally become evident around 3 months post-treatment.
- Duration of Effect: Results are long-lasting, typically ranging from 12 to 18 months, after which maintenance 'top-up' treatments may be desired.
Practical logistics
- Costs should be confirmed on the /pricing/ page before booking
- Preparation: Patients may be advised to avoid anti-inflammatory medications (like ibuprofen) for a few days before the procedure, as these can interfere with the inflammatory healing process initiated by the platelets.
- Post-Treatment Restrictions: Intercourse, strenuous activity, and taking baths should generally be avoided for 48 hours up to 5 days to allow the tissue to begin healing and prevent infection.
Research sources
- Clarke B, et al. (2026). Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A randomised Controlled Trial. Obstetrics & gynaecology.
- Hersant B, et al. (2018). Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer. Menopause.
- Sukgen G, et al. (2019). Platelet-rich plasma administration to the lower anterior vaginal wall to improve female sexuality satisfaction. Turkish Journal of Obstetrics and gynaecology.
- Hamid ASA, et al. (2025). Value of injection of plasma-rich platelets in the vaginal mucosa in cases with vulvovaginal atrophy: a prospective double-blinded randomised controlled study. BMC Women's Health.
Regulatory resources
Authoritative resources
These resources support assessment-led, evidence-aware patient information.
NICE interventional procedures guidance
NICE is a UK authority for interventional procedure governance and supports cautious language about evidence, consent and audit.
FDA safety communication on vaginal rejuvenation devices
This safety communication is a useful regulatory reference for avoiding over-claiming around sexual enhancement procedures.
RCOG patient information on menopause symptom treatment
RCOG patient information supports assessment-led discussion of vaginal dryness, discomfort and hormone-related symptoms.
Next step
Book a clinical consultation
A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 240 imported records. Additional reviewed material included peer-reviewed clinical papers; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This information is provided for educational and informational purposes only and does not constitute medical advice. While platelet-rich plasma (PRP) treatments like the O-Shot have early clinical interest for relieving discomfort during intimacy, individual results may vary. Always consult with an appropriately qualified healthcare provider to accurately diagnose the root cause of dyspareunia and to determine the safest, most appropriate treatment plan for your specific medical history. Results vary. Not a cure.
